# Neal Rosen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/neal-rosen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 55,736 |
| Field | Melanoma and MAPK Pathways |
| h-index | 127 |
| i10-index | 259 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5060228803 |
| ORCID iD | https://orcid.org/0000-0002-8307-654X |
| Works | 1,009 |

## Researcher papers

- [BRAF mutation predicts sensitivity to MEK inhibition](https://scholariq.org/papers/braf-mutation-predicts-sensitivity-to-mek-inhibition/)
- [<sup>V600E</sup> BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway](https://scholariq.org/papers/sup-v600e-sup-braf-is-associated-with-disabled-feedback-inhibition-of-raf-mek/)
- [Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas](https://scholariq.org/papers/relief-of-profound-feedback-inhibition-of-mitogenic-signaling-by-raf-inhibitors/)
- [The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner](https://scholariq.org/papers/the-raf-inhibitor-plx4032-inhibits-erk-signaling-and-tumor-cell-proliferation-in/)
- [PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer](https://scholariq.org/papers/pi3k-inhibition-results-in-enhanced-estrogen-receptor-function-and-dependence-in/)
- [Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation](https://scholariq.org/papers/small-molecule-mapk-inhibitors-restore-radioiodine-incorporation-in-mouse/)
- [Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i> -Mutant Thyroid Carcinomas](https://scholariq.org/papers/relief-of-feedback-inhibition-of-i-her3-i-transcription-by-raf-and-mek/)
- [Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence](https://scholariq.org/papers/loss-of-nf1-in-cutaneous-melanoma-is-associated-with-ras-activation-and-mek/)
- [Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors](https://scholariq.org/papers/reactivation-of-erk-signaling-causes-resistance-to-egfr-kinase-inhibitors/)
- [HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers](https://scholariq.org/papers/her2-mediated-internalization-of-cytotoxic-agents-in-i-erbb2-i-amplified-or/)
- [Genetic Predictors of MEK Dependence in Non–Small Cell Lung Cancer](https://scholariq.org/papers/genetic-predictors-of-mek-dependence-in-non-small-cell-lung-cancer/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Synthesis and biological activity](https://scholariq.org/topics/synthesis-and-biological-activity/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.